Search results
AbbVie (ABBV) Starts Late-Stage Study on Multiple Myeloma Drug
Zacks via Yahoo Finance· 9 hours agoThe late-stage study will evaluate AbbVie's (ABBV) experimental antibody to treat patients with...
...Elahere Meets Primary Goal In Mid-Stage Study In Heavily Pretreated Ovarian Cancer Patients - ...
Benzinga· 8 hours agoOn Thursday, AbbVie Inc ABBV released topline results from the Phase 2 PICCOLO trial evaluating...
AbbVie treats first subject in Phase III multiple myeloma drug trial
Clinical Trials Arena via Yahoo Finance· 16 hours agoIn April, the company reported positive top-line data from the first period of the Phase III...
2 High-Yield Dividend Stocks to Buy Right Now | The Motley Fool
The Motley Fool· 1 day agoDividend stocks are sensitive to interest rates. When rates fall, studies show that money managers...
AbbVie’s RINVOQ now indicated for paediatric arthritis in US
Pharmaceutical Technology via Yahoo Finance· 2 days agoAbbVie has announced that its RINVOQ (upadacitinib) is now indicated for treating polyarticular...
AbbVie (ABBV) Skyrizi Gets CHMP Nod for Ulcerative Colitis in EU
Zacks via Yahoo Finance· 3 days agoAbbVie (ABBV) announces that the EMA's CHMP issued a positive opinion on its regulatory filing...
AbbVie (ABBV) Could Be a Great Choice
Zacks· 4 days agoWhile cash flow can come from bond interest or interest from other types of investments, income investors hone in on dividends. A dividend is the distribution of a company's earnings paid out ...
ASCO: Replacing chemotherapy with ADCs? AbbVie rebuilds next-gen assets after Rova-T flop
FierceBiotech· 2 days agoA new trend has emerged at this year’s American Society of Clinical Oncology conference: the...
ASCO 2024: AbbVie flexes early success of ADC pipeline in solid tumours
Clinical Trials Arena via Yahoo Finance· 4 days agoDaejin Abidoye, head of solid tumour oncology, development at AbbVie in an interview with Clinical...
AbbVie Receives Positive CHMP Opinion for Risankizumab (SKYRIZI®) for the Treatment of Adults with...
telegraphherald.com· 7 days agoThe positive opinion is based on results from two pivotal Phase 3 trials, INSPIRE and COMMAND, that evaluated the efficacy and safety of risankizumab in adults with moderately to severely